Table 1 Subject demographics
n | Mean (SD) | |
|---|---|---|
Age (years) | 5 | 64 (5) |
Time since diagnosis (years) | 5 | 8 (5) |
UPDRS Part III Score (baseline) | 5 | 20 (5) |
n | Percentage | |
|---|---|---|
Male sex | 5 | 100 |
Caucasian race | 5 | 100 |
Levodopa equivalent dose at baseline and at the end of study | ||
0 mg and 200 mga | 1 | 20 |
142.5 mg and 427.5 mg | 1 | 20 |
400 mg and 800 mg | 1 | 20 |
600 mg and 800 mg | 1 | 20 |
800 mg and 800 mg | 1 | 20 |